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Introduction: Sepsis is defined as a systemic hyper-inflammatory immune response, with a subsequent
immune-suppressive phase, which leads to multiple organ dysfunction and late lethality. Receptor-interacting
protein kinase 3 (RIPK3)-dependent necrosis is implicated in driving tumor necrosis factor alpha (TNF-α)- and
sepsis-induced mortality in mice. However, it is unknown if RIPK3 deficiency has any impact on immune cell
trafficking, which contributes to organ damage in sepsis.
Methods: To study this, male wild-type (WT) and RIPK3-deficient (Ripk3−/−) mice on C57BL/6 background were
subjected to sham operation or cecal ligation and puncture (CLP)-induced sepsis. Blood and tissue samples were
collected 20 hours post-CLP for various measurements.
Results: In our severe sepsis model, the mean survival time of Ripk3−/− mice was significantly extended to 68 hours
compared to 41 hours for WT mice. Ripk3−/− mice had significantly decreased plasma levels of TNF-α and IL-6 and
organ injury markers compared to WT mice post-CLP. In the lungs, Ripk3−/− mice preserved better integrity of
microscopic structure with reduced apoptosis, and decreased levels of IL-6, macrophage inflammatory protein
(MIP)-2 and keratinocyte-derived chemokine (KC), compared to WT. In the liver, the levels of MIP-1, MIP-2 and KC
were also decreased in septic Ripk3−/− mice. Particularly, the total number of neutrophils in the lungs and liver of
Ripk3−/− mice decreased by 59.9% and 66.7%, respectively, compared to WT mice post-CLP. In addition, the number
of natural killer (NK) and CD8T cells in the liver decreased by 64.8% and 53.4%, respectively, in Ripk3−/− mice
compared to WT mice post-sepsis.
Conclusions: Our data suggest that RIPK3 deficiency modestly protected from CLP-induced severe sepsis and
altered the immune cell trafficking in an organ-specific manner attenuating organ injury. Thus, RIPK3 acts as a
detrimental factor in contributing to the organ deterioration in sepsis.Introduction
Sepsis afflicts >800,000 people annually with the mortality
rate as high as 30% [1] which accounts for up to 39% of
total hospital costs in the United States [2], yet there is a
lack of effective therapies for the sickest patients in inten-
sive care units [3]. Sepsis is an acute clinical condition de-
fined as an initial systemic hyper-inflammatory immune
response associated with a proven or suspected infection,* Correspondence: pwang@nshs.edu
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unless otherwise stated.which eventually progresses to multiple organ dysfunction
(severe sepsis), intractable hypotension (septic shock) and
lethality [4]. Along with inflammation designed to
eliminate the underlying pathogen, immune-suppressive
mechanisms are also initiated during sepsis which result
in immune dysfunctions and secondary infections [5,6].
An exaggerated and sustained proinflammatory cytokine
response to the pathogen-associated molecular patterns
(PAMPs) from invading microorganisms and damage-
associated molecular patterns (DAMPs) released from
dying cells in the circulation, as well as an excessive organ
infiltration of leukocytes resulting in organ failure, are
hallmarks of severe sepsis [7,8]. Sepsis is also characterized
by the massive cell death of various cell types includingl Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
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such as intestinal cells and hepatocytes [9-11]. Cell death
occurs through morphologically distinct processes of
apoptosis and necrosis. Unlike apoptosis which is pro-
grammed cell death, necrosis has been considered as an
accidental and unregulated form of cell death occurring
due to metabolic failure [12,13]. Until recently, it has been
recognized that the process of necrotic cell death induced
by TNF-α can be programmed as apoptosis, hence called
necroptosis [14,15].
The receptor-interacting protein kinase 3 (RIPK3) is a
member of the family of serine/threonine protein kinases
with a unique C-terminal domain, while its N-terminal kin-
ase domain is similar to other RIPK family members includ-
ing RIPK1, RIPK2 and RIPK4 [16-18]. RIPK3 was shown to
function as a molecular switch between TNF-α-induced
apoptosis and necrosis via interaction with RIPK1 forming
a necrosis signaling complex (necrosome) for triggering
necroptosis [19-23]. Recently, RIPK3-dependent necrosis
has been shown to be responsible for the mortality of sep-
tic mice induced either by TNF-α injection or polymicro-
bial sepsis, suggesting that targeting necrotic cells could
be a novel and promising therapeutic approach for improv-
ing sepsis outcome [24,25]. RIPK3-mediated necroptosis can
initiate a ‘cell death storm’ in sepsis with the release of
DAMPs, such as high-mobility group box 1 (HMGB1),
IL-1α, DNA fragments, mitochondrial content, uric acid,
ATP, heat shock proteins and cold-inducible RNA-binding
protein (CIRP) to provoke a strong inflammatory response
[24,26,27]. However, the association of RIPK3 with leukocyte
recruitment under such conditions remains to be studied.
Hence, determining the effects of ablation of RIPK3-
mediated necrosis on the trafficking of various subtypes of
immune cells and resultant organ injury following sepsis
is critical for the development of therapies for patients.
In the present study, using RIPK3-deficient (Ripk3−/−)
mice in a physiologically relevant model of severe polymi-
crobial sepsis induced by cecal ligation and puncture
(CLP), we examined the role of RIPK3 in altering immune
cell trafficking and organ injury in sepsis. We showed that
RIPK3 deficiency significantly prolonged the survival and
attenuated acute lung and liver injury in severe septic
mice. Furthermore, RIPK3 deficiency resulted in the re-
duction of infiltration of neutrophils, natural killer (NK)
cells and CD8+ T lymphocytes in an organ specific man-
ner. Thus, RIPK3 played a crucial role in altering immune
cell trafficking during sepsis, which may suggest targeting
RIPK3 as a therapeutic strategy in attenuating organ injury
caused by excessive immune cell infiltration in sepsis.
Material and methods
Mice
C57BL/6 mice matched for gender and age were either
purchased from Taconic (Albany, NY, USA) or bred inour own facility and used as wild type (WT) control mice.
Ripk3−/− mice [28] were provided by V. Dixit (Genentech,
San Francisco, CA, USA). Male C57BL/6 or Ripk3−/− mice
were used at the age of 8- to 12-weeks. Mice were housed
in a temperature-controlled room on a 12 hour light/dark
cycle and fed a standard laboratory diet within the Feinstein
Institute for Medical Research (Manhasset, NY, USA). All
experiments were performed in accordance with the guide-
lines for the use of experimental animals by the National
Institutes of Health (Bethesda, MD, USA) and were ap-
proved by the Institutional Animal Care and Use Committee
(IACUC) at the Feinstein Institute for Medical Research.
Cecal ligation and puncture
CLP was used as a model of polymicrobial sepsis. The
mice were anesthetized by isoflurane inhalation, and the
abdomen was shaved and washed with 10% povidone
iodine. A 1- to 2-cm midline incision was performed to
allow exposure of the cecum and tightly ligated 1.5 cm
from the tip with a 4–0 silk suture. Double puncture of
the cecum with a 22-gauge needle was performed. The
cecum was then gently squeezed to extrude sufficient
amount of feces from the perforation sites and returned
to the peritoneal cavity. The laparotomy site was then
closed with 6–0 silk suture. Sham operated animals under-
went the same procedure with the exception that the
cecum was neither ligated nor punctured. The CLP ani-
mals were resuscitated with 1 ml of isotonic sodium chlor-
ide solution by subcutaneous injection immediately after
the surgery to improve dehydration after CLP. At 20 hours
after CLP or sham operation, mice were anesthetized and
blood, liver and lungs were collected. A section of lung tis-
sue was preserved in formalin for histopathology. Blood
samples were centrifuged at 3,000 g for 10 minutes to col-
lect plasma. The plasma and the remainder of the tissue
samples were frozen immediately in liquid nitrogen and
stored at −80°C until analysis. An additional set of experi-
ments was performed for harvesting the liver and lungs
for leukocyte preparation 20 hours post-CLP or sham. For
the survival study, mice were administered the antibiotic,
Primaxin (Merck & Co., Whitehouse Station, NJ, USA)
(0.5 mg/kg) subcutaneously following the CLP procedure
and were monitored for seven days to record survival.
Measurements of pro-inflammatory cytokines and organ
injury markers
Pro-inflammatory cytokines TNF-α and IL-6 were
quantified by using the specific mouse ELISA kits
(BD Biosciences, Franklin Lakes, NJ, USA) in plasma
and lung tissue. Plasma levels of aspartate aminotrans-
ferase (AST), alanine aminotransferase (ALT) and lactate
dehydrogenase (LDH) were measured using commercial
assay kits (Pointe Scientific, Lincoln Park, MI, USA) accor-
ding to the manufacturer’s instructions.
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The lung tissue was fixed in 10% formalin and later em-
bedded in paraffin. The tissue blocks were then cut into
5 μm sections, transferred to glass slides and stained
with H & E. Morphologic alterations in the lung tissues
were examined by light microscopy and documented by
photographs. Lung injury was assessed using a blinded,
semiquantitative scoring system as absent, mild, moder-
ate, or severe injury (score 0 to 3, respectively) according
to the following pathological features: (1) focal alveolar
membrane thickening, (2) capillary congestion, (3) intra-
alveolar hemorrhage, (4) interstitial leukocyte infiltra-
tion, and (5) intra-alveolar leukocyte infiltration, and a
cumulative total histology score was determined.
Leukocyte suspension preparation from liver and lungs
Hepatic leukocytes were isolated from livers that were
minced and homogenized in PBS with 1% fetal bovine
serum (FBS), followed by density gradient centrifugation
(2,000 rpm, 20 minutes) using 44% and 66% Percoll (GE
Healthcare Bio-Sciences AB, Uppsala, Sweden). Lung
leukocytes were isolated by digesting minced lungs in
Roswell Park Memorial Institute (RPMI) medium con-
taining 100 U/ml collagenase type 1 (Worthington Bio-
chemical, Lakewood, NJ, USA) and 20 U/ml DNase 1
(Roche Diagnostics, Mannheim, Germany) for 30 minutes
at 37°C in a shaker incubator followed by Percoll-gradient
centrifugation. Cells at the interface and below were col-
lected, washed and counted.
Antibodies and flow cytometry
Single cell suspensions (1 × 106 cells) obtained from dif-
ferent organs were pre-incubated with anti–CD16/CD32
(93) to block FcγRII/III receptors and stained with the
desired antibodies (Abs) on ice for 30 minutes and ana-
lyzed on FACSVerse (BD Bioscience, San Jose, CA, USA).
The following anti-mouse Abs conjugated to fluorescein
isothiocyanate (FITC), phycoerythrin (PE), peridinin chlo-
rophyll protein-cyanine 5.5, allophycocyanin or PE-cya-
nine7 (all from Biolegend, San Diego, CA, USA) were
used for staining: anti-Gr-1 (RB6-8C5) and anti-CD11b
(M1/70), anti-CD4 (GK1.5/RM4-5), anti-CD8α (53–6.7),
anti-TCRβ (H57-597), anti-NK1.1 (PK136). Dead cells
were excluded by forward light scatter or forward light
scatter plus propidium iodide. All the data were acquired
and presented on log scale. Data were analyzed by FlowJo
software (Tree Star, Ashland, OR, USA).
Myeloperoxidase activity assay
Lung tissues were homogenized in potassium phosphate
buffer containing 0.5% hexa-decyl-trimethyl-ammonium
bromide. After centrifugation the supernatant was diluted
in reaction solution, and the rate of change in opticaldensity (OD) for two minutes was measured at 460 nm to
calculate myeloperoxidase (MPO) activity.
Real-time RT-PCR analysis
Total RNA was extracted from lung and liver tissues
using TRIzol reagent (Invitrogen, Carlsbad, CA, USA)
and was reverse-transcribed into cDNA using murine
leukemia virus reverse transcriptase (Applied Biosystems,
Foster City, CA, USA). A PCR reaction was carried out in
25 μl of a final volume containing 0.1 μM of each forward
and reverse primer, cDNA and 12.5 μl SYBR Green PCR
Master Mix (Life Technologies, Grand Island, NY, USA).
Amplification was conducted using an Applied Biosystems
7300 real-time PCR machine (Applied Biosystems) and
analyzed by the 2-ddCt method for relative quantization
normalized to mouse β-actin mRNA. Relative expression
of mRNA was expressed as the fold change in comparison
with the sham tissues. The primers used for this study are
listed in Table 1.
TUNEL assay
The presence of apoptotic cells in the lung sections were
assessed using a TUNEL staining kit (Roche Diagnostics)
according to the manufacturer’s instructions. The negative
control was performed by incubating slides in the mixture
containing only deoxynucleotidyl transferase. TUNEL-
positive cells were counted in five fields/section under a
fluorescence microscope (×200), and the number of cells/
field are shown.
Western blotting
Lung tissue was homogenized by sonication in lysis buffer
(10 mM Tris–HCl, pH 7.5, 120 mM NaCl, 1% NP-40, 1%
sodium deoxycholate and 0.1% SDS) containing a protease
inhibitor cocktail (Roche Diagnostics). Total lung lysates
were fractionated on Bis-Tris gels (4% to 12%), transferred
to nitrocellulose membrane, immunoblotted with anti-
cleaved caspase-3 or anti-cleaved caspase-8 (Cell Signaling
Technology, Beverly, MA, USA) or anti-β-actin (Sigma-
Aldrich, St Louis, MO, USA) Abs and visualized by using
Pierce ECL 2 Western Blotting Substrate (Thermo
Scientific, Southfield, MI, USA).
Statistical analysis
Data are expressed as mean ± standard error of the mean
(SEM) and analyzed using SigmaPlot11 graphing and stat-
istical analysis software (Systat Software Inc., San Jose, CA,
USA). Multiple groups were compared by one-way analysis
of variance (ANOVA) using the Student-Newman-Keuls’
(SNK) test. Student’s t test was used for two-group analysis.
The survival data were analyzed using the Kaplan-Meier
method and compared by the log-rank test. Differences in
values were considered significant if P <0.05.
Table 1 Sequences of the primers used in RT-PCR
Gene name Forward primer sequence Reverse primer sequence
Cxcl3 (MIP-1) AGGTCCCTGTCATGCTTCTG TCTGGACCCATTCCTTCTTG
Cxcl2 (MIP-2) CCCTGGTTCAGAAAATCATCCA GCTCCTCCTTTCCAGGTCAGT
Cxcl1 (KC) GCTGGGATTCACCTCAAGAA ACAGGTGCCATCAGAGCAGT
Actb (β-actin) CGTGAAAAGATGACCCAGATCA TGGTACGACCAGAGGCATACAG
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RIPK3 deficiency prolongs survival and reduces systemic
injury in CLP-induced acute sepsis
We first performed a seven-day survival study on WT and
Ripk3−/− mice to confirm the effect of RIPK3 deficiency
on a very severe model of CLP-induced polymicrobial
sepsis. The WT mice group had 100% mortality on day 2,
whereas Ripk3−/− mice group had 100% mortality on day
6 (Figure 1A). The mean survival time of septic WT mice
was about 41 hours, whereas that of septic Ripk3−/− mice
was about 68 hours. Therefore, RIPK3 deficiency exerted
a protective effect as shown by prolonging survival of
severely septic mice.
Since excessive elevation of pro-inflammatory cyto-
kines in circulation is a major contributor to remote
organ injury after CLP, we then examined the plasma
levels of pro-inflammatory cytokines. TNF-α and IL-6
plasma levels were both significantly increased in WT
and Ripk3−/− mice 20 hours after CLP, compared to each
sham group (Figure 1B, 1C). However, the levels of
TNF-α and IL-6 in septic Ripk3−/− mice were 59.2% and
56.6%, respectively, lower than those in septic WT mice
(Figure 1B, 1C). Similarly, the serum levels of the organ
injury markers AST, ALT, and LDH were all significantly
increased in WT and Ripk3−/− mice 20 hours after CLP,
compared to each sham group (Figure 1D-F). The levels
of AST, ALT and LDH in septic Ripk3−/− mice were
21.2%, 31.5% and 29.2%, respectively, lower than those
in septic WT mice (Figure 1D-F). Taken together, these
results indicated that RIPK3 deficiency resulted in the
reduction of pro-inflammatory cytokines and organ in-
jury markers in septic mice.
RIPK3 deficiency attenuates CLP-induced damage of
lungs
CLP-induced sepsis resulted in acute lung injury (ALI)
and lung dysfunction is the first step in the development
of multiple organ failure. The lung tissues of WT mice
20 hours after CLP showed substantial morphological
changes, including alveolar collapse, edema, hemorrhage
and infiltration of inflammatory cells (Figure 2A, upper).
In contrast, the lung tissues of septic Ripk3−/− mice ex-
hibited less microscopic deterioration (Figure 2A, lower).
As quantified in Figure 2B, the lung histological injury
score in septic WT mice significantly increased by 16.7fold compared to the sham group, while this score was
reduced by 36% in septic Ripk3−/− mice. These data sug-
gest that RIPK3 deficiency improved lung morphology in
CLP-induced severe sepsis.
To investigate the effect of RIPK3 deficiency on apop-
tosis, a TUNEL assay, which is a common method for
detecting DNA fragmentation, was conducted by immu-
nohistochemistry in the lung tissues. The TUNEL-positive
cells in the lung tissues of WT and Ripk3−/− mice were
well detected after CLP compared to the sham groups
(Figure 2C). However, the number of TUNEL-positive
cells in the lung tissues of Ripk3−/− mice after CLP was
significantly reduced by 58.1% compared with WT mice
after CLP (Figure 2D). In addition, expression of cleaved
caspase-3 and caspase-8 in the lung tissues of WT mice
was increased after CLP compared to the sham procedure,
whereas such an increase was not observed in Ripk3−/−
mice after CLP (Figure 2E). Our data suggest that absence
of RIPK3 also protects lungs from apoptotic cell death in
ALI induced by sepsis.
RIPK3 deficiency reduces neutrophil infiltration in the
lungs after CLP
ALI also results in local proinflammatory cytokine and
chemokine overproduction, so we checked their expres-
sion in the lungs. The mRNA levels of macrophage
inflammatory protein 1 (MIP-1), MIP-2, and keratinocyte-
derived chemokine (KC) determined by RT-PCR increased
by 67-, 1,852-, and 327-fold, respectively, in WT mice
after CLP (Figure 3A-C). Although the mRNA levels
of MIP-1, MIP-2, and KC were also increased in sep-
tic Ripk3−/− mice, their levels were reduced by 30.2%,
90.9%, and 68.4%, respectively, compared to the septic
WT mice (Figure 3A-C). Similarly, IL-6 protein levels
in the lungs of septic Ripk3−/− mice were decreased
by 86.2% compared to those in septic WT mice
(Figure 3D).
Chemokines mediate neutrophil infiltration into the
lungs, which is the hallmark of ALI. We determined the
MPO activity which reflects neutrophil infiltration. As
expected, lung MPO activity of septic WT mice was
significantly increased by 9.8-fold compared to sham
(Figure 3E). Septic Ripk3−/− mice showed significantly
reduced (down by 32.9%) lung MPO activity as com-
pared with that of septic WT mice. To further confirm
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Figure 1 Ripk3−/− mice have prolonged survival and reduced systemic injury after CLP. (A) WT (n = 15) and Ripk3−/− mice (n = 13) were
subjected to CLP as described in Material and Methods for a seven-day survival study. *P <0.05 versus WT. (B-F) WT and Ripk3−/− mice underwent
sham- or CLP-operation and blood samples were collected at 20 hours after CLP for the analysis of plasma levels of the cytokines TNF-α (B) and
IL-6 (C) and serum organ injury markers AST (D), ALT (E) and LDH (F). Data are expressed as mean ± SEM (n = 5 per group). *P <0.05 versus WT
sham, #P <0.05 versus WT CLP. ND: nondetectable. ALT, alanine aminotransferase; AST, aspartate aminotransferase; CLP, cecal ligation and
puncture; SEM, standard error of the mean; WT, wild type.
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the lung tissues to isolate leukocytes and then stained
them with Gr-1 and CD11b surface markers to identify
neutrophils. Frequency and the number of Gr-1+CD11b+
neutrophils in the lungs of WT mice was significantly
increased by 3.8- and 7.1-fold, respectively, after CLP as
compared to sham WT mice (Figure 3F, 3G). Such in-
crease in frequency and the number of neutrophils was re-
duced by 43.3% and 59.9%, respectively, in septic Ripk3−/−
mice in comparison with septic WT mice (Figure 3F, 3G).
These results collectively show that RIPK3 deficiency
attenuates lung neutrophil infiltration associated with
reduction of chemokines and cytokines.RIPK3 deficiency attenuates neutrophil infiltration in liver
after CLP
Since ALT is a relatively specific indicator of liver damage
and it was found to be increased in septic mice, we then
examined the neutrophil infiltration in acute liver injury in-
duced by sepsis. First, we determined the mRNA levels of
MIP-1, MIP-2 and KC by RT-PCR and showed a 54-,
2,218- and 346-fold increase, respectively, in septic WT
mice, compared to sham WT mice (Figure 4A-C). The
mRNA levels of MIP-1, MIP-2 and KC in septic Ripk3−/−
mice were reduced by 43.3%, 92.4% and 67.5%, respect-
ively, as compared with the septic WT mice (Figure 4A-C).
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Figure 2 Ripk3−/− mice have attenuated lung damage after CLP. The lung tissues from WT and Ripk3−/− mice were harvested 20 hours after
sham- or CLP-operation. (A) Representative lung histology sections (H & E staining; original magnification × 200) and (B) the lung injury scores
from the above mentioned mice groups determined as described in Materials and Methods are shown. (C) Representative TUNEL staining
(green fluorescent) and nuclear counterstaining (red fluorescent) of lung sections (original magnification × 200) and (D) the number of
apoptotic cells quantified from TUNEL staining (averaged over 10 microscopic fields per mouse) is shown. (E) Representative blots
for cleaved caspase-3 and caspase-8 in the lung tissues are presented and β-actin is used as a loading control. Data expressed as
means ± SEM (n = 5 per group). *P <0.05 versus WT sham and #P <0.05 versus WT CLP. CLP, cecal ligation and puncture; SEM, standard error of
the mean; WT, wild type.
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and 43.6-fold, respectively, after CLP as compared to the
sham WT mice (Figure 4D, 4E). Such increase in the fre-
quency and the number of neutrophil was reduced by
51.7% and 66.7%, respectively, in septic Ripk3−/− mice in
comparison with septic WT mice (Figure 4D, 4E). To-
gether, the data suggest that similar to lung injury, RIPK3
deficiency also attenuates the CLP-induced liver injury
partly by reducing the chemokine-mediated neutrophil
infiltration.RIPK3 deficiency inhibits the elevation of natural killer
and CD8T cells in liver after CLP
Apart from neutrophils, migrating natural killer (NK)
cells are also known to facilitate inflammation and injury
in sepsis [29]. So we examined the NK cells in the liver
of WT and Ripk3−/− mice under sham and CLP condi-
tions 20 hours post-operation. To evaluate the NK cells,
we stained hepatic leukocytes with NK1.1 and TCRβ
surface markers to define NK1.1+TCRβ− NK cells. The
frequency and number of NK cells in the liver of WT





























































































































































































Figure 3 Ripk3−/− mice show decreased chemokine expression and neutrophil infiltration in the lungs after CLP. The lung tissues from
WT and Ripk3−/− mice were harvested 20 hours after sham- or CLP- operation. (A-C) The mRNA levels of MIP-1 (A), MIP-2 (B) and KC (C) in the
lungs were determined by real-time RT-PCR analysis and expressed as fold change relative to WT sham. (D) Lung levels of IL-6 were determined
by ELISA. (E) Lung myeloperoxidase (MPO) activity was determined spectrophotometrically. (F) Flow cytometric analysis of surface Gr-1/CD11b
expression on gated live lung leukocytes from sham- or CLP-operated WT and Ripk3−/− mice. Numbers adjacent to outlined areas show the
percentage of Gr-1+CD11b+ neutrophils in the representative dot blots as indicated. (G) The graphs show percentage (upper) and absolute
numbers (lower) of Gr-1+CD11b+ neutrophils in the lungs as indicated. Data are expressed as mean ± SEM (n = 5 per group). *P <0.05 versus WT
sham and #P <0.05 versus WT CLP. CLP, cecal ligation and puncture; KC, keratinocyte-derived chemokine; MIP, macrophage inflammatory protein;
SEM, standard error of the mean; WT, wild type.
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4.4-fold, respectively, as compared to sham WT mice
(Figure 5A, 5B). Whereas, the frequency and number of
NK cells in septic Ripk3−/− mice were decreased by
61.7% and 64.8%, respectively, in comparison with those
in septic WT mice (Figure 5A, 5B).
Combined deficiency of CD8T and NK cells is known
to be beneficial in CLP-induced murine sepsis [30,31].Also, CLP-induced sepsis is known to result in reduced
numbers of peripheral CD8T cells. In contrast, a marked
increase in hepatic CD8T cells which induces FasL-
mediated inflammation and hepatocyte apoptosis has
been reported [32]. So we examined the CD8T in liver
of WTand Ripk3−/− mice under sham and CLP conditions
20 hours post-operation. To evaluate the lymphocytes, we
stained hepatic leukocytes with CD4 and CD8 surface
Figure 4 Ripk3−/− mice show decreased chemokine expression and neutrophil infiltration in liver after CLP. The liver tissues from WT and
Ripk3−/− mice were harvested 20 hours after sham- or CLP-operation. (A-C) The mRNA levels of MIP-1 (A), MIP-2 (B), and KC (C) in the liver tissues
were determined by real-time RT-PCR analysis and expressed as fold change relative to WT sham. (D) Flow cytometric analysis of surface Gr-1/
CD11b expression on gated live hepatic leukocytes from sham- or CLP-operated WT and Ripk3−/− mice. Numbers adjacent to outlined areas show
the percentage of Gr-1+CD11b+ neutrophils in the representative dot blots as indicated. (E) The graphs show percentage (upper) and absolute
numbers (lower) of Gr-1+CD11b+ neutrophils in the livers as indicated. Data are expressed as mean ± SEM (n = 5 per group). *P <0.05 versus WT
sham and #P <0.05 versus WT CLP. CLP, cecal ligation and puncture; KC, keratinocyte-derived chemokine; MIP, macrophage inflammatory protein;
SEM, standard error of the mean; WT, wild type.
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and number of CD8T cells in the liver of WT mice
were significantly increased after CLP by 1.8- and 2.6-
fold, respectively, as compared to sham WT mice 022
(Figure 6A, 6B) whereas, the frequency and number
of CD8T cells in septic Ripk3−/− mice were decreased
by 44.2% and 53.4%, respectively, in comparison with
those in septic WT mice (Figure 6A, 6B). These data
collectively suggest that RIPK3 mediates liver specificNK and CD8T cell trafficking in CLP-induced sepsis
possibly contributing to liver injury.
Discussion
In this study, we demonstrate that RIPK3 deficiency pro-
longs survival in severe septic mice induced by CLP and
reduces systemic levels of pro-inflammatory cytokines as
well as organ injury markers. In particular, we show that
RIPK3 deficiency attenuates CLP-induced ALI resulting
A B
Figure 5 Ripk3−/− mice show decreased NK infiltration in liver after CLP. The liver tissues from WT and Ripk3−/− mice were harvested
20 hours after sham- or CLP-operation and hepatic leukocytes were isolated. (A) Flow cytometric analysis of surface NK1.1/TCRβ expression on
gated live hepatic leukocytes. Numbers adjacent to outlined areas show the percentage of NK cells (NK1.1+TCRβ−) in the representative dot blots
as indicated. (B) The graphs show the percentage and absolute numbers of NK cells in the liver as indicated. Data are expressed as mean ± SEM
(n = 8 per group). *P <0.05 versus WT sham and #P <0.05 versus WT CLP. CLP, cecal ligation and puncture; NK, natural killer; SEM, standard error of
the mean; WT, wild type.
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apoptotic cell death in lung epithelium, and decreased
local pro-inflammatory cytokine and chemokine produc-
tion. Finally, we demonstrate that RIPK3 deficiency re-
duces CLP-induced neutrophil infiltration in the lungs,
whereas in the liver it not only decreases the neutrophil
infiltration but also decreases NK and CD8T cell accu-
mulation. In the light of these observations we propose
that RIPK3 deficiency attenuates CLP-induced organ in-
jury by inhibiting the infiltration of immune cells in an
organ-specific manner and, thus, protects against sepsis.
Whether the alteration in immune cell trafficking is a
direct result of RIPK3 deficiency or an indirect response
to reduced necrotic DAMPs remains to be established.
Sepsis-induced cell death has been observed in various
organs and cell types in murine models. For example, an
increase of apoptosis has been reported in the lungs,
spleen, thymus, gut epithelial cells and gut-associated
lymphoid tissues [6,33,34]. However, hepatocytes show
modest increase in apoptosis but major increase in
necrosis in septic animals [35]. This indicates that themode of cell death and damage pattern is tissue-specific
[10]. Sepsis patients showed increased levels of both apop-
totic and necrotic cell death markers [36]. However, in
severe septic patients with hepatic dysfunction, the loss of
parenchymal cells due to increased necrosis was found to
be the primary mode of cell death [36]. This suggested
that, unlike apoptosis, hepatocyte necrosis is an early pre-
dictor of disease outcome in septic patients with liver dys-
function. On the other hand, it has also been reported
that patients who died about six days after the onset of
sepsis do not have much tissue necrosis observed in heart
and kidneys [37]. With the accumulated studies, it is still
not clear whether necrosis or apoptosis plays the predom-
inant role in contributing to the severity of sepsis.
In agreement with the earlier report [24], we demon-
strate that, even in our very severe model of CLP-induced
sepsis, RIPK3 deficiency delayed mortality. Duprez et al.
had shown that in their CLP-model, after severe-CLP the
WT mice showed 70% mortality on day 3, whereas the
majority of Ripk3−/− mice (>80%) survived. However, un-
like the previous study, our CLP-induced sepsis model
A B
Figure 6 Ripk3−/− mice show decreased CD8T cells in liver after CLP. The liver tissues from WT and Ripk3−/− mice were harvested 20 hours
after sham- or CLP-operation and hepatic leukocytes were isolated. (A) Flow cytometric analysis of surface CD4/CD8 expression on gated live
hepatic lymphocytes. Numbers adjacent to outlined areas show the percentage of CD8T cells in the representative dot blots as indicated. (B) The
graphs show the percentage and absolute numbers of CD8T cells in the livers as indicated. Data are expressed as mean ± SEM (n = 8 per group).
*P <0.05 versus WT sham and #P <0.05 versus WT CLP. CLP, cecal ligation and puncture; SEM, standard error of the mean; WT, wild type.
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after CLP in the WT mice group, and the Ripk3−/− mice
group shows delayed mortality but still 100% mortality on
day 6 after CLP. Our sepsis model is more representative
of the refractory shock and massive systemic inflammation
phase that leads to acute multiorgan failure with associ-
ated tissue necrosis, which represents a sub-fraction of
sepsis cases in clinic. Whether RIPK3 plays a role in regu-
lating the immunosuppressive phase of sepsis and altering
the susceptibility to secondary infections needs to be fur-
ther addressed in a milder CLP model and/or a second hit
model with bacterial infection. Although, under very
severe conditions, eliminating RIPK3 cannot provide a
beneficial effect on the long-term survival, its effect on
prolongation of survival time suggests that inhibition of
necroptosis may extend the treatment window for other
therapeutic agents.
The previous study on polymicrobial sepsis in the
absence of RIPK3 has only shown reduced systemic
DAMPS, cytokines and LDH but did not investigate theorgan specific damage [24]. The lung is the first and
most seriously injured organ during sepsis-induced mul-
tiple organ failure. Indeed, we show a decrease in the
lung histological injury score and the number of apop-
totic cells, indicative of reduced ALI in RIPK3-deficient
mice. We also find decreased local IL-6 production and
neutrophil-attracting chemokine expression in the lungs
lacking RIPK3. As migration of neutrophils into the
lungs plays a key role in inducing ALI, we show that the
dramatic neutrophil infiltration in the lungs seen after
CLP in control mice reduces by almost half when RIPK3
is depleted. Interestingly, we noted that the decrease in
the numbers of other lung lymphocytes (CD4, CD8, NK
and natural killer T cells (NKT)) after CLP was not af-
fected by RIPK3 presence or absence (data not shown).
We also note no change in the sepsis-induced decrease
of various lymphocyte subsets in the thymus and spleen
of Ripk3−/− mice in comparison with WT mice (data not
shown), which suggests that the lymphocyte loss due to
apoptosis does not depend on RIPK3-driven necroptosis
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other immune cells, was affected in the lungs by RIPK3
deficiency in septic mice.
Considering that necrosis plays a major role in sepsis
induced liver dysfunction, we next wanted to look at the
effect of RIPK3 deficiency in sepsis-induced liver damage.
As we expected, the ALT levels (used as liver damage
indicator) which increased in WT mice after CLP are sig-
nificantly reduced by 31.5% in the absence of RIPK3. We
show that the chemokine expression in liver tissue is also
severely decreased in the absence of RIPK3. Next, we
demonstrate that similar to the lungs, the dramatic neu-
trophil infiltration in the liver seen after CLP in control
mice is also reduced by almost half when RIPK3 is
depleted. This suggests reduced chemotactic infiltration of
neutrophils in RIPK3-deficient livers. Interestingly, we
note that RIPK3-deficient mice still show liver damage
after CLP-induced sepsis in our model, though much less
than WT mice. This also points toward the fact that
eliminating necroptosis is beneficial but it is not the only
factor contributing to liver damage during severe sepsis,
leaving a role for apoptosis and passive necrosis.
NK cells have been shown to participate in the early
eradication of bacteria in the liver, peritoneal lavage and
circulation during sepsis, likely due to their interactions
with macrophages [38]. However, excessive migration of
NK cells into the peritoneal cavity amplifies the proin-
flammatory activities of myeloid cells during septic
shock [29]. In this study we report for the first time an
increase in the hepatic NK cell population after CLP-
induced sepsis specifically in the liver (not seen in lungs)
which is attenuated after RIPK3 deficiency. We also
noted that 20 hours after CLP, the intensity and level of
increased CD69 expression on liver NK cells is similar
between Ripk3−/− mice and WT mice (data not shown),
which suggests that RIPK3 deficiency does not affect the
activation of NK cells in sepsis, but rather decreases
their infiltration in the liver. This is in agreement with
the previous study which showed no difference in the
capacity of the Ripk3−/− mice to clear infection in their
CLP-induced sepsis model [24]. When monitoring the
immune cell trafficking, we did not treat the septic mice
with antibiotics in order to obtain the maximal deterior-
ation after CLP. However, in the survival study, septic
mice were immediately administered antibiotics after CLP.
Whether lowering the bacterial load by antibiotics can
change the pattern of immune cell trafficking in RIPK3
deficient mice after CLP needs further investigation.
Sherwood et al. have shown that double deficiency of
NK cells and CD8T cells is beneficial for survival in sepsis
[30,31]. As reported previously [32], we find that hepatic
CD8T cells are significantly increased after CLP as com-
pared to sham in the WT mice but not in Ripk3−/− mice.
Interestingly, our study shows that RIPK3 deficiencyresults in a liver specific combined decrease in NK and
CD8T cells after sepsis. The reason or mechanism for
accumulation of CD8+ T cells as well as NK cells in the
septic liver is not yet clear. The possibility of a detrimental
role for CD8+T cells in liver injury, particularly via activa-
tion of local tissue inflammation and apoptotic signaling
in sepsis has been suggested [32]. Whether hepatic NK
cells have a direct role in causing liver injury and inflam-
mation during sepsis needs to be further investigated.
However, cytotoxicity of hepatic NK cells in the liver has
been reported previously [39,40], although not in sepsis.
Since we observe almost no increase in liver-specific NK
and CD8T cells after sepsis in the absence of RIPK3, it is
reasonable to suggest that recruitment of these cell sub-
sets to the liver is possibly associated with necrotopic liver
damage.
Conclusions
In conclusion, data provided in this study show that
RIPK3 plays a role in altering sepsis-induced immune cell
trafficking in an organ-specific manner and its deficiency
attenuates organ damage as well as modestly prolongs
survival.
Key messages
 RIPK3 deficiency prolongs survival in severe septic
mice induced by CLP and reduces systemic levels
of pro-inflammatory cytokines as well as organ
injury markers.
 RIPK3 deficiency attenuates CLP-induced ALI
resulting in improved integrity of lung architecture,
reduced apoptotic cell death in lung epithelium and
decreased local pro-inflammatory cytokine and
chemokine production.
 RIPK3 deficiency reduces CLP-induced neutrophil
infiltration in the lungs, whereas in the liver it not
only decreases the neutrophil infiltration but also
decreases NK and CD8T cell accumulation.
 RIPK3 deficiency attenuates CLP-induced organ
injury by inhibiting the infiltration of immune cells
in an organ-specific manner and, thus, protects
against sepsis.
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